Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP781594.RAD_4bRFr-Btb8bdCAa0dlo41x5vMSeElH2ryFlKYL8js130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP781594.RAD_4bRFr-Btb8bdCAa0dlo41x5vMSeElH2ryFlKYL8js130_assertion type Assertion NP781594.RAD_4bRFr-Btb8bdCAa0dlo41x5vMSeElH2ryFlKYL8js130_head.
- NP781594.RAD_4bRFr-Btb8bdCAa0dlo41x5vMSeElH2ryFlKYL8js130_assertion description "[The 2001 World Health Organization (WHO)-sponsored classification of hematopoietic tumors has, for the first time, clearly defined a group of rare myeloid neoplasms termed myelodysplastic/myeloproliferative diseases (MDS/MPDs).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP781594.RAD_4bRFr-Btb8bdCAa0dlo41x5vMSeElH2ryFlKYL8js130_provenance.
- NP781594.RAD_4bRFr-Btb8bdCAa0dlo41x5vMSeElH2ryFlKYL8js130_assertion evidence source_evidence_literature NP781594.RAD_4bRFr-Btb8bdCAa0dlo41x5vMSeElH2ryFlKYL8js130_provenance.
- NP781594.RAD_4bRFr-Btb8bdCAa0dlo41x5vMSeElH2ryFlKYL8js130_assertion SIO_000772 18480833 NP781594.RAD_4bRFr-Btb8bdCAa0dlo41x5vMSeElH2ryFlKYL8js130_provenance.
- NP781594.RAD_4bRFr-Btb8bdCAa0dlo41x5vMSeElH2ryFlKYL8js130_assertion wasDerivedFrom befree-20150227 NP781594.RAD_4bRFr-Btb8bdCAa0dlo41x5vMSeElH2ryFlKYL8js130_provenance.
- NP781594.RAD_4bRFr-Btb8bdCAa0dlo41x5vMSeElH2ryFlKYL8js130_assertion wasGeneratedBy ECO_0000203 NP781594.RAD_4bRFr-Btb8bdCAa0dlo41x5vMSeElH2ryFlKYL8js130_provenance.